Latex Allergy: Current Status and Future Perspectives

References

• Dennis R, Ownby A. History of latex allergy. J Allergy Clin Immunol. 2002;110(2):S27–S32. doi:10.1067/mai.2002.12533612170240
   PubMed Web of Science ®Google Scholar
• Stern G. Überempfindlichkeit gegen Kautschuk als ursache von Urticaria und quinckeschem odem. Klin Wochenschr. 1927;6:1096–1097.
   Google Scholar
• Grimm A. Uberempfindlichtkeit gegen kautschuk als uorsache von urticaria und quinckeschem ödem. Klin Wochenschr. 1927;6:1479. doi:10.1007/BF01718534
   Google Scholar
• Nutter AF. Contact urticaria to rubber. Br J Dermatol. 1979;101(5):597–598. doi:10.1111/j.1365-2133.1979.tb11893.x518831
   PubMed Web of Science ®Google Scholar
• Wu M, McIntosh J, Liu J. Current prevalence rate of latex allergy: why it remains a problem? J Occup Health. 2016;58:138–144. doi:10.1539/joh.15-0275-RA27010091
   PubMed Web of Science ®Google Scholar
• Cremer R, Mennicken O. Longitudinal study on specific IgE against natural rubber latex, banana and kiwi in patients with spina bifida. Klin Padiatr. 2011;223(06):352–355. doi:10.1055/s-0031-127375221512968
   PubMed Web of Science ®Google Scholar
• Blumchen K, Bayer P, Buck D, et al. Effects of latex avoidance on latex sensitization, atopy and allergic diseases in patients with spina bifida. Allergy. 2010;65(12):1585–1593. doi:10.1111/j.1398-9995.2010.02447.x20659078
   PubMed Web of Science ®Google Scholar
• Tomazic VJ, Shampaine EL, Lamanna A, Withrow TJ, Adkinson NF Jr, Hamilton RG. Cornstarch powder on latex products is an allergen carrier. J Allergy Clin Immunol. 1994;93(4):751–758. doi:10.1016/0091-6749(94)90255-08163784
   PubMed Web of Science ®Google Scholar
• Agarwal N, McDonnell S, Khan W. Management of latex hypersensitivity in the perioperative setting. J Perioper Pract. 2020;30(7–8):199–203. doi:10.1177/175045891988222231694472
   PubMedGoogle Scholar
• Brehler R, Theissen U, Mohr C, Luger T. Latex‐fruit syndrome: frequency of cross‐reacting IgE antibodies. Allergy. 1997;52:404–410. doi:10.1111/j.1398-9995.1997.tb01019.x9188921
   PubMed Web of Science ®Google Scholar
• Garcia Ortiz JC, Moyano JC, Alvarez M, Bellido J. Latex allergy in fruit‐allergic patients. Allergy. 1998;53:532–536. doi:10.1111/j.1398-9995.1998.tb04092.x9636814
   PubMed Web of Science ®Google Scholar
• Werfel T, Asero R, Ballmer-Weber BK, et al. Position paper of the EAACI: food allergy due to immunological cross-reactions with common inhalant allergens. Allergy. 2015;70(9):1079–1090. doi:10.1111/all.1266626095197
   PubMed Web of Science ®Google Scholar
• Shaffrali FC, Gawkrodger DG. Allergic contact dermatitis from natural rubber latex without immediate hypersensitivity. Contact Dermatitis. 1999;40:325–326. doi:10.1111/j.1600-0536.1999.tb06084.x10385336
   PubMed Web of Science ®Google Scholar
• Leuzzi M, Vincenzi C, Sechi A, et al. Delayed hypersensitivity to natural rubber latex: does it exist or not? Contact Dermatitis. 2019;81(5):404–405. doi:10.1111/cod.1335331290999
   PubMed Web of Science ®Google Scholar
• Alenius H, Kurup VP, Kelly KJ, Palosuo T, Turjanmaa K, Fink JN. Latex allergy: frequent occurrence of IgE antibodies to a cluster of 11 latex proteins in patients with spina bifida and histories of anaphylaxis. J Lab Clin Med. 1994;123(5):712–720.8195677
   PubMed Web of Science ®Google Scholar
• Kurup VP, Alenius H, Kelly KJ, Castillo L, Fink JN. A two-dimensional electrophoretic analysis of latex peptides reacting with IgE and IgG antibodies from patients with latex allergy. Int Arch Allergy Immunol. 1996;109(1):58–67. doi:10.1159/0002372328527952
   PubMed Web of Science ®Google Scholar
• Lu LJ, Kurup VP, Hoffman DR, Kelly KJ, Murali PS, Fink JN. Characterization of major latex allergen associated with hypersensitivity in spina bifida patients. J Immunol. 1995;155:2721–2728.7650400
   PubMed Web of Science ®Google Scholar
• Bernstein DI, Biagini RE, Karnani R, et al. In vivo sensitization to purified Hevea brasiliensis proteins in health care workers sensitized to natural rubber latex. J Allergy Clin Immunol. 2003;111(3):610–616. doi:10.1067/mai.2003.16412642845
   PubMed Web of Science ®Google Scholar
• Slater J, Vedvick T, Arthur-Smith A, Trybul DE, Kekwick RG. Identification, cloning, and sequence of a major allergen (Hev b 5) from natural rubber latex (Hevea brasiliensis). J Biol Chem. 1996;271(41):25394–25399. doi:10.1074/jbc.271.41.253948810306
   PubMed Web of Science ®Google Scholar
• Kotovuori A, Poikonen S, Niskanen E, et al. Isolated hevein-like domains, but not 31-kd endochitinases, are responsible for IgE mediated in vitro and in vivo reactions in latex-fruit syndrome. J Allergy Clin Immunol. 2005;115:598–605. doi:10.1016/j.jaci.2004.09.01515753910
   PubMed Web of Science ®Google Scholar
• Blanco C, Diaz-Perales A, Collada C, et al. Class I chitinases as potential panallergenes involved in the latex-fruit syndrome. J Allergy Clin Immunol. 1999;103:507–513. doi:10.1016/S0091-6749(99)70478-110069887
   PubMed Web of Science ®Google Scholar
• Rolland M 1, o’Hehir RE. Latex allergy: a model for therapy. Clin Exp Allergy. 2008;38(6):898–912. doi:10.1111/j.1365-2222.2008.02984.x18498539
   PubMed Web of Science ®Google Scholar
• Nucera E, Rizzi A, Buonomo A, et al. The clinical meaning of positive latex sige in patients with food/pollen adverse reactions. Int J Immunopathol Pharmacol. 2012;25(2):445–453. doi:10.1177/03946320120250021422697076
   PubMed Web of Science ®Google Scholar
• Chen Z, Cremer R, Posch A, Raulf-Heimsoth M, Rihs HP, Baur X. On the allergenicity of Hev b 1 among health care workers and patients with spina bifida allergic to natural rubber latex. J Allergy Clin Immunol. 1997;100(5):684–769. doi:10.1016/s0091-6749(97)70174-x9389300
   PubMed Web of Science ®Google Scholar
• Rihs HP, Sander I, Heimann H, Meurer U, Brüning T, Raulf M. The new latex allergen Hev b 15: IgE-binding properties of a recombinant serine protease inhibitor. J Investig Allergol Clin Immunol. 2015;25(2):133–162.
   Web of Science ®Google Scholar
• Woods JA, Lambert S, TAE P-M, Drake DB, Edlich R. Natural rubber latex allergy: spectrum, diagnostic approach, and therapy. J Emerg Med. 1997;15(1):71–85. doi:10.1016/s0736-4679(96)00256-99017491
   PubMedGoogle Scholar
• Liccardi G, D’Amato G, Canonica W, Salzillo A, Piccolo A, Passalacqua G. Systemic reactions from skin testing: literature review. J Investig Allergol Clin Immunol. 2006;16(2):75–78.
   PubMed Web of Science ®Google Scholar
• Kelly KJ, Kurup VP, Zacharisen M, Resnick A, Fink JN. Skin and serologic testing in the diagnosis of latex allergy. J Allergy Clin Immunol. 1993;91:1140–1145.8509577
   PubMed Web of Science ®Google Scholar
• Nicolaou N, Johnston GA. Anaphylaxis following prick testing with natural rubber latex. Contact Dermatitis. 2002;47:251–252. doi:10.1034/j.1600-0536.2002.470422.x12492542
   PubMed Web of Science ®Google Scholar
• Nettis E, Dambra P, Traetta PL, Loria MP, Ferranini A, Tursi A. Systemic reactions on SPT to latex. Allergy. 2001;56:355–356. doi:10.1034/j.1398-9995.2001.00862.x11284810
   PubMed Web of Science ®Google Scholar
• Van Kampen V, Raulf-Heimsoth M, Sander I, Merget R. Diagnostics of occupational type I allergies-comparison of skin prick test solutions from different manufacturers for selected occupational allergens. Pneumologie. 2010;64(5):271–277.20455174
   PubMedGoogle Scholar
• Bendewald MJ, Farmer SA, Davis MD. An 8-year retrospective review of patch testing with rubber allergens: the mayo clinic experience. Dermatitis. 2010;21(1):33–40. doi:10.2310/6620.2009.0902920137737
   PubMed Web of Science ®Google Scholar
• Ebo DG, Bridts CH, Rihs HP. Hevea latex associated allergies: piecing together the puzzle of the latex IgE reactivity profile. Expert Rev Mol Diagn. 2020;20(4):367–373. doi:10.1080/14737159.2020.173081732056456
   PubMed Web of Science ®Google Scholar
• Nowakowska-Świrta E, Wiszniewska M, Walusiak-Skorupa J. Allergen-specific IgE to recombinant latex allergens in occupational allergy diagnostics. J Occup Health. 2019;61(5):378–386. doi:10.1002/1348-9585.1206431090202
   PubMed Web of Science ®Google Scholar
• Sanz ML, García-Avilés MC, Tabar AI, et al. Basophil activation test and specific IgE measurements using a panel of recombinant natural rubber latex allergens to determine the latex allergen sensitization profile in children. Pediatr Allergy Immunol. 2006;17(2):148–156. doi:10.1111/j.1399-3038.2005.00359.x16618365
   PubMed Web of Science ®Google Scholar
• Agache I, Bilò MB, Braunstahl GJ, et al. In vivo diagnosis of allergic diseases–allergen provocation tests. Allergy. 2015;70(4):355–365. doi:10.1111/all.1258625640808
   PubMed Web of Science ®Google Scholar
• Nucera E, Pollastrini E, Sabato V, et al. Challenge tests in the diagnosis of latex allergy. Int J Immunopathol Pharmacol. 2010;23(2):543–552. doi:10.1177/03946320100230021620646349
   PubMed Web of Science ®Google Scholar
• Vandenplas O, Suojalehto H, Aasen TB, et al. Specific inhalation challenge in the diagnosis of occupational asthma: consensus statement. Eur Respir J. 2014;43(6):1573‐1587. doi:10.1183/09031936.00175113
   Web of Science ®Google Scholar
• Chelminska M, Niedoszytko M, Jassem E. Clinical value of conjunctival allergen challenge in diagnosing allergic conjunctivitis related to latex. Int Arch Allergy Immunol. 2011;154(2):149‐154.
   Web of Science ®Google Scholar
• Cabañes N, Igea JM, de la Hoz B, et al. Latex allergy: position paper. J Investig Allergol Clin Immunol. 2012;22(5):313–330.
   Web of Science ®Google Scholar
• Bernstein DI. Management of natural rubber latex allergy. J Allergy Clin Immunol. 2002;110(2):S111. doi:10.1067/mai.2002.12533012170251
   PubMed Web of Science ®Google Scholar
• Palosuo T, Antoniadou I, Gottrup F, Phillips P. Latex medical gloves: time for a reappraisal. Int Arch Allergy Immunol. 2011;156:234–246. doi:10.1159/00032389221720169
   PubMed Web of Science ®Google Scholar
• Kelly KJ, Wang ML, Klancnik M, Petsonk EL. Prevention of IgE sensitization to latex in health care workers after reduction of antigen exposures. J Occup Environ Med. 2011;53(8):934–940. doi:10.1097/JOM.0b013e31822589dc21775898
   PubMed Web of Science ®Google Scholar
• Allergen nomenclature. Available from: http://www.allergen.org/search.php?allergensource=Hevea+brasiliensis . Accessed September 17, 2020.
   Google Scholar
• Vandenplas O, Raulf M. Occupational latex allergy: the current state of affairs. Curr Allergy Asthma Rep. 2017;17(3):14. doi:10.1007/s11882-017-0682-528251426
   PubMed Web of Science ®Google Scholar
• Korniewicz DM, Chookaew N, El-Masri M, Mudd K, Bollinger ME. Conversion to low-protein, powder-free surgical gloves: is it worth the cost? Am Assoc Occup Health Nurses. 2005;53(9):388–393.
   Google Scholar
• Yip E, Cacioli P. The manufacture of gloves from natural rubber latex. J Allergy Clin Immunol. 2002;110(Suppl 2):S3–14. doi:10.1067/mai.2002.12449912170237
   PubMed Web of Science ®Google Scholar
• Critchley E, Pemberton MN. Latex and synthetic rubber glove usage in UK general dental practice: changing trends. Heliyon. 2020;6(5):e03889.32405551
   PubMed Web of Science ®Google Scholar
• Raulf M. Current state of occupational latex allergy. Curr Opin Allergy Clin Immunol. 2020;20(2):112–116. doi:10.1097/ACI.000000000000061131850921
   PubMed Web of Science ®Google Scholar
• Cornish K. Assessment of the risk of type I latex allergy sensitization or reaction during use of products made from latex derived from guayule and other alternative rubber producing species. Rubber Sci. 2012;25:139–155.
   Google Scholar
• Caballero ML, Quirce S. Identification and practical management of latex allergy in occupational settings. Expert Rev Clin Immunol. 2015;11(9):977–992. doi:10.1586/1744666X.2015.105975426099284
   PubMed Web of Science ®Google Scholar
• Crepy MN. Rubber: new allergens and preventive measures. Eur J Dermatol. 2016;26(6):523–530. doi:10.1684/ejd.2016.283928007673
   PubMed Web of Science ®Google Scholar
• CDC’s recommendations on the use of PPE during the COVID-19 outbreak. Available from: https://www.cdc.gov/coronavirus/2019-ncov/infection-control/controlrecommendations.html. Accessed 815, 2020.
   Google Scholar
• Food and Drug Administration. Enforcement policy for gowns, other apparel, and gloves during the Coronavirus Disease (COVID–19) public health emergency. Guidance for Industry and Food and Drug Administration Staff (March 2020). Docket Number FDA–2020–D–1138. Available from: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/enforcement-policy-gowns-other-apparel-and-gloves-during-coronavirus-disease-covid-19-public-health. Accessed 629, 2020.
   Google Scholar
• Food and Drug Administration. Process for Making Available Guidance Documents Related to Coronavirus Disease. 2019 Available from: https://www.govinfo.gov/content/pkg/FR-2020-03-25/pdf/2020-06222.pdf. Accessed 629, 2020.
   Google Scholar
• Allmers H, Schmengler J, Skudlik C. Primary prevention of natural rubber latex allergy in the German health care system through education and intervention. J Allergy Clin Immunol. 2002;110(2):318–323. doi:10.1067/mai.2002.12646112170275
   PubMed Web of Science ®Google Scholar
• Nieto A, Mazon A, Pamies R, et al. Efficacy of latex avoidance for primary prevention of latex sensitization in children with spina bifida. J Pediatr. 2002;140(3):370–372. doi:10.1067/mpd.2002.12273211953738
   PubMed Web of Science ®Google Scholar
• Cremer R, Kleine-Diepenbruck U, Hering F, Holschneider AM. Reduction of latex sensitization in spina bifida patients by a primary prophylaxis programme (five years experience). Eur J Pediatr Surg. 2002;12:S19–S21. doi:10.1055/s-2002-3686612541209
   PubMed Web of Science ®Google Scholar
• Stinkens R, Verbeke N, Van de Velde M, et al. Safety of a powder-free latex allergy protocol in the operating theatre: a prospective, observational cohort study. Eur J Anaesthesiol. 2019;36(4):312–313. doi:10.1097/EJA.000000000000095330817368
   PubMed Web of Science ®Google Scholar
• American Society of Anesthesiologists Committee on Occupational Health of Operating Room Personnel. Natural Ruber Latex Allergy: Considerations for Anesthesiologists. Park Ridge, IL: American Society of Anesthesiologists; 2005.
   Google Scholar
• Australasian Society of Clinical Immunology and Allergy. ASCIA Guidelines – Management of Latex-Allergic Individuals. Balgowlah NSW: Australasian Society of Clinical Immunology and Allergy; 2010.
   Google Scholar
• Sussman GL, Lem D, Liss G, Beezhold D. Latex allergy in housekeeping personnel. Ann Allergy Asthma Immunol. 1995;74:415–418.7749973
   PubMed Web of Science ®Google Scholar
• Sanguanchaiyakrit N, Povey AC, de Vocht F. Personal exposure to inhalable dust and the specific latex aero-allergen, Hev b6.02, in latex glove manufacturing in Thailand. Ann Occup Hyg. 2014;58:542–550. doi:10.1093/annhyg/meu01324569810
   PubMedGoogle Scholar
• Havmose M, Thyssen JP, Zachariae C, Johansen JD. Use of protective gloves by hairdressers: a review of efficacy and potential adverse effects. Contact Dermatitis. 2020;83(2):75–82. doi:10.1111/cod.1356132311093
   PubMed Web of Science ®Google Scholar
• Madan I, Cullinan P, Ahmed SM. Occupational management of type I latex allergy. Occup Med. 2013;63(6):395–404. doi:10.1093/occmed/kqt055
   Google Scholar
• Crepy MN, Lecuen J, Ratour-Bigot C, Stocks J, Bensefa-Colas L. Accelerator-free gloves as alternatives in cases of glove allergy in healthcare workers. Contact Dermatitis. 2018;78(1):28–32. doi:10.1111/cod.1286028748553
   PubMed Web of Science ®Google Scholar
• Gentili A, Lima M, Ricci G, et al. Secondary prevention of latex allergy in children: analysis of results. Pediatr Med Chir. 2006;28:83.17533902
   PubMedGoogle Scholar
• Reider N, Kretz B, Menardi G, Ulmer H, Fritsch P. Outcome of a latex avoidance program in a high‐risk population for latex allergy – a five‐year follow‐up study. Clin Exp Allergy. 2002;32(5):708–713. doi:10.1046/j.1365-2222.2002.01390.x11994094
   PubMed Web of Science ®Google Scholar
• Crippa M, Belleri L, Mistrello G, Tedoldi C, Alessio L. Prevention of latex allergy among health care workers and in the general population: latex protein content in devices commonly used in hospitals and general practice. Int Arch Occup Environ Health. 2006;79(7):550–557. doi:10.1007/s00420-005-0080-516468057
   PubMed Web of Science ®Google Scholar
• Emergency treatment of anaphylactic reactions. Guidelines for healthcare providers. Working Group of the Resuscitation Council (UK). 2016 Available from: www.resus.org.uk. Accessed 815, 2020.
   Google Scholar
• Truhlář A, Deakin CD, Soar J, et al. Cardiac arrest in special circumstances section collaborators. European resuscitation council guidelines for resuscitation 2015: section 4. Cardiac arrest in special circumstances. Resuscitation. 2015;95:148–201. doi:10.1016/j.resuscitation.2015.07.01726477412
   PubMed Web of Science ®Google Scholar
• Kraft M, Dölle-Bierke S, Turner PJ, et al. EAACI task force clinical epidemiology of anaphylaxis: experts’ perspective on the use of adrenaline autoinjectors in Europe. Clin Transl Allergy. 2020;10(1):12. doi:10.1186/s13601-020-00317-y32426107
   PubMed Web of Science ®Google Scholar
• Noon L. Prophylactic inoculation against hay fever. Lancet. 1911;1:1572–1573. doi:10.1016/S0140-6736(00)78276-6
   Google Scholar
• Freeman J. Further observation on the treatment of hay-fever by hypodermic inoculation of pollen vaccine. Lancet. 1911;2:814–817. doi:10.1016/S0140-6736(01)40417-X
   Google Scholar
• Ring J, Gutermuth J. 100 years of hyposensitization: history of allergen-specific immunotherapy (ASIT). Allergy. 2011;66(6):713–724. doi:10.1111/j.1398-9995.2010.02541.x21320133
   PubMed Web of Science ®Google Scholar
• Nucera E, Schiavino D, Pollastrini E, et al. Desensitization to latex by percutaneous route. J Investig Allergol Clin Immunol. 2002;12:134–135.
   PubMed Web of Science ®Google Scholar
• Patriarca G, Nucera E, Buonomo A, et al. Latex allergy desensitization by exposure protocol: five case reports. Anesth Analg. 2002;94:754–758.11867411
   PubMed Web of Science ®Google Scholar
• Pereira C, Rico P, Lourenço M, Lombardero M, Pinto-Mendes J, Chieira C. Specific immunotherapy for occupational latex allergy. Allergy. 1999;54:291–293. doi:10.1034/j.1398-9995.1999.00954.x10321572
   PubMed Web of Science ®Google Scholar
• Leynadier F, Herman D, Vervloet D, Andre C. Specific immunotherapy with a standardized latex extract versus placebo in allergic healthcare workers. J Allergy Clin Immunol. 2000;106(3):585–590. doi:10.1067/mai.2000.10917310984382
   PubMed Web of Science ®Google Scholar
• Sastre J, Fernández-Nieto M, Rico P. Specific immunotherapy with a standardized latex extract in allergic workers: a double-blind, placebo-controlled study. J Allergy Clin Immunol. 2003;111(5):985–994. doi:10.1067/mai.2003.139012743562
   PubMed Web of Science ®Google Scholar
• Tabar AI, Anda M, Bonifazi F, et al. Specific Immunotherapy with standardized latex extract versus placebo in latex-allergic patients. Int Arch Allergy Immunol. 2006;141(4):369–376. doi:10.1159/00009546316943675
   PubMed Web of Science ®Google Scholar
• Nucera E, Schiavino D, Buonomo A, et al. Latex rush desensitization. Allergy. 2001;56:86–87. doi:10.1034/j.1398-9995.2001.00904.x
   PubMed Web of Science ®Google Scholar
• Smith DM, Freeman TM. Sublingual immunotherapy for other indications: venom large local, latex, atopic dermatitis, and food. Immunol Allergy Clin North Am. 2020;40(1):41–57. doi:10.1016/j.iac.2019.09.01131761120
   PubMed Web of Science ®Google Scholar
• Nettis E, Delle Donne P, Di Leo E, et al. Latex immunotherapy: state of the art. Ann Allergy Asthma Immunol. 2012;109(3):160–165. doi:10.1016/j.anai.2012.07.00422920069
   PubMed Web of Science ®Google Scholar
• Patriarca G, Nucera E, Roncallo C, et al. Sublingual desensitization: a new approach to latex allergy problem. Anesth Analg. 2002;95:956–960. doi:10.1097/00000539-200210000-0003112351276
   PubMed Web of Science ®Google Scholar
• Cistero Bahima A, Sastre J, Enrique E, et al. Tolerance and effects on skin reactivity to latex of sublingual rush immunotherapy with a latex extract. J Investig Allergol Clin Immunol. 2004;14:17–25.
   PubMed Web of Science ®Google Scholar
• Antico A, Pagani M, Crema A. Anaphylaxis by latex sublingual immunotherapy. Allergy. 2006;61(10):1236–1237. doi:10.1111/j.1398-9995.2006.01155.x16942577
   PubMed Web of Science ®Google Scholar
• Nettis E, Colanardi MC, Soccio AL, et al. Double-blind, placebo-controlled study of sublingual immunotherapy in patients with latex-induced urticaria: a 12-month study. Br J Dermatol. 2007;156(4):674–681. doi:10.1111/j.1365-2133.2006.07738.x17493066
   PubMed Web of Science ®Google Scholar
• Bernardini R, Campodonico P, Burastero S, et al. Sublingual immunotherapy with a latex extract in paediatric patients: a double-blind, placebo-controlled study. Curr Med Res Opin. 2006;22(8):1515–1522. doi:10.1185/030079906X11571116870076
   PubMed Web of Science ®Google Scholar
• Bernardini R, Pecora S, Milani M, Burastero SE. Natural rubber latex allergy in children: clinical and immunological effects of 3-years sublingual immunotherapy. Eur Ann Allergy Clin Immunol. 2008;40(4):142–147.19227650
   PubMedGoogle Scholar
• Nucera E, Schiavino D, Pollastrini E, et al. Sublingual desensitization in children with congenital malformations and latex. Allergy Pediatr Allergy Immunol. 2006;17(8):606–612. doi:10.1111/j.1399-3038.2006.00458.x17121589
   PubMed Web of Science ®Google Scholar
• Nucera E, Schiavino D, Sabato V, et al. Sublingual immunotherapy for latex allergy: tolerability and safety profile of rush build-up phase. Curr Med Res Opin. 2008;24(4):1147–1154. doi:10.1185/030079908X29190318334054
   PubMed Web of Science ®Google Scholar
• Buyukozturk S, Gelincik A, Ferhan F, Colakoğlu B, Dal M. Latex sublingual immunotherapy: can its safety be predicted? Ann Allergy Asthma Immunol. 2010;104:339–342. doi:10.1016/j.anai.2010.01.01420408345
   PubMed Web of Science ®Google Scholar
• Lasa Luaces EM, Tabar Purroy AI, García Figueroa BE, et al. Component-resolved immunologic modifications, efficacy, and tolerance of latex sublingual immunotherapy in children. Ann Allergy Asthma Immunol. 2012;108(5):367–372. doi:10.1016/j.anai.2012.03.00522541410
   PubMed Web of Science ®Google Scholar
• Nucera E, Mezzacappa S, Buonomo A, et al. Latex immunotherapy: evidence of effectiveness. Postepy Dermatol Alergol. 2018;35(2):145–150. doi:10.5114/ada.2018.7523529760613
   PubMed Web of Science ®Google Scholar
• Morfin Maciel BM, Castillo Morfin BM. Failure of sublingual immunotherapy to treat latex allergy. A report of a case. Rev Alerg Mex. 2008;55(2):76–81.19058485
   PubMedGoogle Scholar
• Gastaminza G, Algorta J, Uriel O, et al. Randomized, double-blind, placebo controlled clinical trial of sublingual immunotherapy in natural rubber latex allergic patients. Trials. 2011;12:191. doi:10.1186/1745-6215-12-19121827704
   PubMed Web of Science ®Google Scholar
• Nucera E, Urbani S, Buonomo A, Andriollo G, Aruanno A. Eosinophilic Esophagitis during latex desensitization. J Investig Allergol Clin Immunol. 2020;30(1):61–63. doi:10.18176/jiaci.0440
   Web of Science ®Google Scholar
• Alfredo J, Lucendo AJ, Arias A, Tenias JM. Relation between eosinophilic esophagitis and oral immunotherapy for food allergy: a systematic review with meta-analysis. Ann Allergy Asthma Immunol. 2014;113:624–629. doi:10.1016/j.anai.2014.08.00425216976
   PubMed Web of Science ®Google Scholar
• Yoshimichi O, Hisako M, Hiroshi O, Shunsuke T, Kimihiro MH. Roles of Omalizumab in various allergic diseases. Allergol Int. 2020;69(2):167–177. doi:10.1016/j.alit.2020.01.00432067933
   PubMed Web of Science ®Google Scholar
• Incorvaia C, Mauro M, Makri E, Leo G, Ridolo E. Two decades with omalizumab: what we still have to learn. Biologics. 2018;12:135–142. doi:10.2147/BTT.S18084630464389
   PubMed Web of Science ®Google Scholar
• Leynadier F, Doudou O, Gaouar H, et al. Effect of omalizumab in healthcare workers with occupational latex allergy. J Allergy Clin Immunol. 2004;113:360–361. doi:10.1016/j.jaci.2003.11.02014767458
   PubMed Web of Science ®Google Scholar
• Di Leo E, Calogiuri G, Macchia L, Nettis E. Use of omalizumab in uncontrolled chronic spontaneous urticaria also improved latex-induced contact urticaria. J Allergy Clin Immunol Pract. 2019;7(1):300–302. doi:10.1016/j.jaip.2018.05.00529802908
   PubMed Web of Science ®Google Scholar
• Aruanno A, Chini R, Nucera E. Efficacy of omalizumab in reducing latex allergy. Postepy Dermatol Alergol. 2020.
   Web of Science ®Google Scholar
• Dantzer JA, Wood RA. The use of omalizumab in allergen immunotherapy. Clin Exp Allergy. 2018;48(3):232–240. doi:10.1111/cea.1308429315922
   PubMed Web of Science ®Google Scholar
• Hu K, Fan J, Li X, Gou X, Li X, Zhou X. The adverse skin reactions of health care workers using personal protective equipment for COVID-19. Medicine. 2020;99(24):e20603. doi:10.1097/MD.000000000002060332541493
   PubMed Web of Science ®Google Scholar
• Raulf M. The latex story. Chem Immunol Allergy. 2014;100:248–255.24925405
   PubMedGoogle Scholar
• Pecora V, Aruanno A, Buonomo A, et al. Sublingual immunotherapy with natural rubber latex: a case report with 8-year follow-up. Contact Dermatitis. 2010;63(1):53–54. doi:10.1111/j.1600-0536.2010.01746.x20597936
   PubMed Web of Science ®Google Scholar